Delay discounting decreases in those completing treatment for opioid dependence
- PMID: 22369670
- PMCID: PMC3972253
- DOI: 10.1037/a0027391
Delay discounting decreases in those completing treatment for opioid dependence
Abstract
Several studies examining both control and substance-dependent populations have found delay discounting to remain stable over time. In this report, we examine whether delay discounting changes in opioid-dependent individuals who complete a 12-week treatment. The 159 subjects who completed discounting assessments at baseline and treatment-end come from two separate clinical trials: 56 from Chopra et al. (2009) and 103 from Christensen et al. (2012). Mean discounting at 12 weeks significantly decreased to less than half (44.8%) of the baseline level (95% CIs (27.5, 73.2)). Analyzing each subject's discounting data individually, over 3 times (95% CIs (1.9, 5.5)) as many subjects statistically decreased their discounting from their own baseline levels than those who exhibited a statistical increase. Though we failed to find any relationship among discounting measures and abstinence outcomes, the results from this large study suggest that treatment for substance dependence promotes decreases in delay discounting.
Conflict of interest statement
Note that Warren K. Bickel, in addition to having academic affiliations, is affiliated with HealthSim, LLC., the health-promotion software development organization that developed the fluency-based, Computer-Assisted Instruction (CAI) technology employed in the computer-based program used in studies that were reanalyzed in the present study. This technology is unique to HealthSim, LLC and was included in the present project because it is an integral part of the web-based program that was evaluated in the study. Dr. Bickel has worked extensively with Virginia Tech Carilion Research Institute to monitor the relationship between these organizations, oversee all aspects of collaborative projects between the organizations, and ensure that no conflict exists between the author’s roles in each organization. The analysis plan and results were conducted by a university statistician with no relationship with HealthSim LLC.
Figures
Similar articles
-
Delay discounting in opioid use disorder: Differences between heroin and prescription opioid users.Drug Alcohol Depend. 2016 Dec 1;169:68-72. doi: 10.1016/j.drugalcdep.2016.10.009. Epub 2016 Oct 17. Drug Alcohol Depend. 2016. PMID: 27776247 Free PMC article.
-
The phenotype of recovery IV: Delay discounting predicts perceived stress and a chance locus of control in individuals in recovery from substance use disorders.Addict Behav Rep. 2020 Nov 28;12:100320. doi: 10.1016/j.abrep.2020.100320. eCollection 2020 Dec. Addict Behav Rep. 2020. PMID: 33364328 Free PMC article.
-
Discounting of delayed rewards in opioid-dependent outpatients: exponential or hyperbolic discounting functions?Exp Clin Psychopharmacol. 1999 Aug;7(3):284-93. doi: 10.1037//1064-1297.7.3.284. Exp Clin Psychopharmacol. 1999. PMID: 10472517 Clinical Trial.
-
Probability discounting of monetary gains and losses in opioid-dependent adults.Behav Brain Res. 2019 May 17;364:334-339. doi: 10.1016/j.bbr.2019.02.017. Epub 2019 Feb 12. Behav Brain Res. 2019. PMID: 30768996
-
Toward a behavioral economic understanding of drug dependence: delay discounting processes.Addiction. 2001 Jan;96(1):73-86. doi: 10.1046/j.1360-0443.2001.961736.x. Addiction. 2001. PMID: 11177521 Review.
Cited by
-
Impulsive choice and pre-exposure to delays: iv. effects of delay- and immediacy-exposure training relative to maturational changes in impulsivity.J Exp Anal Behav. 2018 May;109(3):587-599. doi: 10.1002/jeab.432. Epub 2018 Apr 23. J Exp Anal Behav. 2018. PMID: 29683190 Free PMC article.
-
Lost in Translation: the Gap Between Neurobiological Mechanisms and Psychosocial Treatment Research for Substance Use Disorders.Curr Addict Rep. 2021 Sep;8(3):440-451. doi: 10.1007/s40429-021-00382-8. Epub 2021 Jul 7. Curr Addict Rep. 2021. PMID: 40406375 Free PMC article.
-
Neurocognitive Dysfunctions and Their Therapeutic Modulation in Patients With Methamphetamine Dependence: A Pilot Study.Front Psychiatry. 2020 Jul 2;11:581. doi: 10.3389/fpsyt.2020.00581. eCollection 2020. Front Psychiatry. 2020. PMID: 32714215 Free PMC article.
-
Age differences in the behavioural economics of cannabis use: Do adolescents and adults differ on demand for cannabis and discounting of future reward?Drug Alcohol Depend. 2022 Sep 1;238:109531. doi: 10.1016/j.drugalcdep.2022.109531. Epub 2022 Jun 9. Drug Alcohol Depend. 2022. PMID: 35809475 Free PMC article.
-
Does temporal discounting explain unhealthy behavior? A systematic review and reinforcement learning perspective.Front Behav Neurosci. 2014 Mar 12;8:76. doi: 10.3389/fnbeh.2014.00076. eCollection 2014. Front Behav Neurosci. 2014. PMID: 24659960 Free PMC article. Review.
References
-
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4. Washington, DC: Author; 1994.
-
- Beck RC, Triplett MF. Test–retest reliability of a group-administered paper–pencil measure of delay discounting. Experimental and Clinical Psychopharmacology. 2009;17:345–355. - PubMed
-
- Bickel WK, Amass L, Crean JP, Badger GJ. Buprenorphine dosing every 1, 2, or 3 days in opioid-dependent patients. Psychopharmacology. 1999;146:111–118. - PubMed